What is the treatment for acute gout flare?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Gout Flare

For acute gout flares, first-line treatment should be corticosteroids, NSAIDs, or colchicine, with corticosteroids preferred as first-line therapy in patients without contraindications due to their safety profile and low cost. 1

First-Line Medication Options

Corticosteroids

  • Preferred first-line option for patients without contraindications 1
  • Dosing: Prednisolone 35 mg daily for 5 days 1
  • Benefits: As effective as NSAIDs with fewer adverse effects 1
  • Contraindications: Systemic fungal infections 1
  • Side effects: Mood disorders, elevated blood glucose, immune suppression, fluid retention 1

Colchicine

  • Recommended dosing: 1.2 mg at first sign of flare, followed by 0.6 mg one hour later (maximum 1.8 mg over one hour) 2, 3
  • Most effective when started within 36 hours of symptom onset 2
  • Side effects: Gastrointestinal symptoms (diarrhea, nausea, vomiting, abdominal pain) 2
  • Contraindicated in:
    • Severe renal impairment (GFR <30 mL/min) 2
    • Concomitant use of strong CYP3A4 inhibitors 3
    • Hepatic impairment 2

NSAIDs

  • Use at full FDA-approved anti-inflammatory doses until attack resolves 2
  • No evidence that any specific NSAID (including indomethacin) is superior 1
  • Contraindications: Renal disease, heart failure, cirrhosis, history of GI bleeding 2
  • Side effects: Dyspepsia, GI perforations, ulcers, bleeding 1

Patient-Specific Treatment Algorithm

  1. For patients without contraindications:

    • Corticosteroids (prednisolone 35 mg for 5 days) as first-line therapy 1
  2. For patients with cardiovascular disease:

    • Avoid NSAIDs 4
    • Use colchicine (if renal function normal) or corticosteroids 4
  3. For patients with renal impairment:

    • If GFR <30 mL/min: Avoid colchicine and NSAIDs 2
    • Use glucocorticoids with careful monitoring 2
  4. For severe, multiarticular flares:

    • Consider combination therapy with oral corticosteroids plus colchicine 2
  5. For limited joint involvement (1-2 large joints):

    • Consider intra-articular corticosteroid injection 2

Adjunctive Measures

  • Apply topical ice to affected joint 2, 5
  • Rest the inflamed joint 5
  • Maintain adequate hydration 2

Important Considerations

  • Start treatment as early as possible for best results 2
  • If a patient is already on prophylactic colchicine, they can still receive treatment-dose colchicine for an acute flare (1.2 mg followed by 0.6 mg one hour later), then resume prophylactic dose after 12 hours 3
  • Do not interrupt urate-lowering therapy during acute flares 2
  • IL-1 inhibitors (anakinra, canakinumab) can be considered when first-line agents are contraindicated, ineffective, or poorly tolerated 2

Follow-up

  • Schedule follow-up appointment in 1-2 weeks to discuss potential long-term urate-lowering therapy 2
  • Monitor serum uric acid levels 2
  • Consider prophylactic therapy when initiating urate-lowering therapy to prevent future flares 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Gout Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacologic Management of Gout in Patients with Cardiovascular Disease and Heart Failure.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.